首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

2054851

血脂檢查市場（依檢測類型分類）

Lipid Panel Test Market, By Test Type (Standard Lipid Profile and Advanced Lipid Testing (LDL Particle Number, Apolipoprotein B, Lipoprotein ), By Product Type, By Application, By Prescription Mode, By End User, By Geography )

出版日期: 2026年03月30日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，血脂檢查市場規模將達到 127.8 億美元，到 2033 年將達到 220.4 億美元。預計 2026 年至 2033 年的複合年成長率將達到 8.1%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	127.8億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	8.10%	2033年市場規模預測：	220.4億美元

全球血脂檢查市場是臨床診斷行業的關鍵細分市場，包括全面的血液檢測，用於測量各種膽固醇和三酸甘油酯的水平，以評估心血管疾病的風險。血脂檢查，也稱為血脂譜或血脂圖，可評估患者血液樣本中的總膽固醇、低密度脂蛋白膽固醇 (LDL)、高密度脂蛋白膽固醇 (HDL) 和三酸甘油酯。

這些診斷評估是醫療保健專業人員識別動脈粥狀硬化、冠狀動脈疾病和其他心血管併發症高風險族群的基本篩檢工具。市場上的產品包括多種檢測方法，例如酶法、均相法以及部署在醫院、診斷檢查室和照護現場（POC）環境中的先進自動化調查方法。

隨著文明病的日益普遍、人口老化以及預防醫學意識的不斷增強，全球對血脂檢查的需求持續成長。高通量分析儀、攜帶式檢測設備和數位健康平台等技術的進步，正在革新血脂檢測的便利性和效率，使其在世界各地不同的醫療環境中都能為醫護人員和患者帶來更多便利。

市場動態

全球血脂檢查市場的主要驅動力是心血管疾病、糖尿病和肥胖症在全球範圍內的日益流行，這導致人們對定期血脂監測和篩檢的需求顯著增加。全球人口老化，尤其是在已開發國家，也大大促進了市場成長，因為老年人需要更頻繁地進行心血管風險評估和血脂監測。

診斷設備的科技進步，包括高通量自動化分析儀、就地檢驗設備和攜帶式血脂檢測解決方案的開發，提高了檢測的準確性、效率和可及性，從而推動了市場擴張。政府推行的預防性醫療保健措施、心血管疾病篩檢計畫和健康宣傳宣傳活動等舉措，進一步刺激了市場需求。

然而，市場中存在一些限制因素。先進診斷設備和檢測程序的高成本可能會限制醫療資源匱乏的醫療機構和發展中地區的醫療服務取得。診斷設備核准、品管標準和檢查室認證的嚴格監管要求構成了市場准入壁壘，並增加了製造商的合規成本。此外，部分地區醫療基礎設施不足、熟練的檢測專業人員短缺以及不完善的報銷政策也阻礙了市場成長。

儘管如此，新興市場蘊藏著巨大的機遇，這些市場的特點是醫療基礎設施不斷完善、醫療支出不斷成長以及人們對心血管健康的認知日益提高。人工智慧、機器學習演算法和遠端醫療平台的融合，為開發創新的血脂檢測解決方案和遠端監測功能提供了契機。居家醫療和自我監測設備的趨勢，為面向消費者的便捷血脂檢測產品創造了潛力；同時，診斷設備製造商與醫療服務提供者之間的合作，有望加速全球市場滲透和服務拓展。

本次調查的主要特點

本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
本研究根據以下參數對全球血脂檢查市場的主要參與者進行了分析：公司亮點、產品系列、關鍵亮點、財務表現和策略。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份全球血脂檢查市場報告的目標受群眾外包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師等產業相關人員。
透過分析全球血脂檢查市場中使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第10章競爭格局

Abbott Laboratories
Beckman Coulter Inc.
Hoffmann-La Roche Ltd.
Randox Laboratories Ltd.
Thermo Fisher Scientific Inc.
Siemens Healthcare GmbH
Bio-Rad Laboratories Inc.
Nova Biomedical Corporation
SD Biosensor, Inc.
PTS Diagnostics
Horiba Medical
Elitech Group
Menarini Group
VivaChek Biotech（Hangzhou）Co., Ltd.
Mico Bio Med

第11章分析師建議

機會分析
分析師意見
Coherent Opportunity Map

第12章參考文獻與調查方法

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI8860

Lipid Panel Test Market is estimated to be valued at USD 12.78 Bn in 2026 and is expected to reach USD 22.04 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.1% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 12.78 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	8.10%	2033 Value Projection:	USD 22.04 Bn

The global lipid panel test market represents a critical segment of the clinical diagnostics industry, encompassing comprehensive blood tests that measure various cholesterol and triglyceride levels to assess cardiovascular disease risk. Lipid panel tests, also known as lipid profiles or lipograms, evaluate total cholesterol, low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, and triglycerides in patients' blood samples.

These diagnostic assessments serve as fundamental screening tools for healthcare providers to identify individuals at risk of developing atherosclerosis, coronary artery disease, and other cardiovascular complications. The market encompasses various testing methodologies including enzymatic assays, homogeneous assays, and advanced automated analyzers deployed across hospitals, diagnostic laboratories, and point-of-care settings.

With the increasing prevalence of lifestyle-related diseases, aging populations, and growing awareness of preventive healthcare measures, the demand for lipid panel testing continues to expand globally. The integration of technological advancements such as high-throughput analyzers, portable testing devices, and digital health platforms has revolutionized the accessibility and efficiency of lipid testing procedures, making them more convenient for both healthcare providers and patients across diverse healthcare settings worldwide.

Market Dynamics

The global lipid panel test market is primarily driven by the escalating prevalence of cardiovascular diseases, diabetes, and obesity worldwide, creating substantial demand for regular lipid monitoring and screening procedures. The aging global population, particularly in developed countries, significantly contributes to market growth as elderly individuals require frequent cardiovascular risk assessments and lipid profile monitoring.

Technological advancements in diagnostic equipment, including the development of high-throughput automated analyzers, point-of-care testing devices, and portable lipid testing solutions, enhance testing accuracy, efficiency, and accessibility, thereby driving market expansion. Government initiatives promoting preventive healthcare measures, cardiovascular disease screening programs, and healthcare awareness campaigns further stimulate market demand.

However, the market faces certain restraints including high costs associated with advanced diagnostic equipment and testing procedures, which may limit accessibility in resource-constrained healthcare settings and developing regions. Stringent regulatory requirements for diagnostic device approvals, quality control standards, and laboratory certifications create barriers to market entry and increase compliance costs for manufacturers. Limited healthcare infrastructure, shortage of skilled laboratory professionals, and inadequate reimbursement policies in certain regions also hinder market growth.

Nevertheless, significant opportunities exist in emerging markets with expanding healthcare infrastructure, increasing healthcare expenditure, and growing awareness about cardiovascular health. The integration of artificial intelligence, machine learning algorithms, and telemedicine platforms presents opportunities for developing innovative lipid testing solutions and remote monitoring capabilities. The rising trend of home-based healthcare and self-monitoring devices creates potential for consumer-friendly lipid testing products, while partnerships between diagnostic companies and healthcare providers can facilitate market penetration and service expansion globally.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global lipid panel test market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Abbott Laboratories, Beckman Coulter Inc., F. Hoffmann-La Roche Ltd., Randox Laboratories Ltd., Thermo Fisher Scientific Inc., Siemens Healthcare GmbH, Bio-Rad Laboratories Inc., Nova Biomedical Corporation, SD Biosensor, Inc., PTS Diagnostics, Horiba Medical, Elitech Group, Menarini Group, VivaChek Biotech (Hangzhou) Co., Ltd., and Mico Bio Med.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global lipid panel test market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global lipid panel test market

Market Segmentation

Test Type Insights (Revenue, USD Bn, 2021 - 2033)
Standard Lipid Profile
- Total Cholesterol
- Triglycerides
- Low-Density Lipoprotein (LDL) Cholesterol
- High-Density Lipoprotein (HDL) Cholesterol
Advanced Lipid Testing
- LDL Particle Number (LDL-P)
- Apolipoprotein B (ApoB)
- Lipoprotein(a) (Lp(a))
- Others (HDL Subclasses, VLDL Cholesterol etc.)
Product Type Insights (Revenue, USD Bn, 2021 - 2033)
Devices
- Automated Analyzers
- Point-of-Care Testing Devices
- Spectrophotometers
- Others
Reagents and Kits
- Cholesterol Test Kits
- HDL and LDL Kits
- Triglyceride Test Kits
- Test Strips
- Other Product Types
Application Insights (Revenue, USD Bn, 2021 - 2033)
Hyperlipidemia
Hypertriglyceridemia
Familial Hypercholesterolemia
Hypo Lipoproteinemia
Tangier Disease
Atherosclerosis
Other Lipid Disorders
Prescription Mode Insights (Revenue, USD Bn, 2021 - 2033)
Prescription-Based Testing
Over-the-Counter (OTC) Testing
End User Insights (Revenue, USD Bn, 2021 - 2033)
Hospitals
Specialty Clinics
Pathology Laboratories
Diagnostic Clinics
Ambulatory Surgical Centers
Home Care Settings
Academic and Research Institutes
Regional Insights (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
Abbott Laboratories
Beckman Coulter Inc.
Hoffmann-La Roche Ltd.
Randox Laboratories Ltd.
Thermo Fisher Scientific Inc.
Siemens Healthcare GmbH
Bio-Rad Laboratories Inc.
Nova Biomedical Corporation
SD Biosensor, Inc.
PTS Diagnostics
Horiba Medical
Elitech Group
Menarini Group
VivaChek Biotech (Hangzhou) Co., Ltd.
Mico Bio Med

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Lipid Panel Test Market, By Test Type
- Global Lipid Panel Test Market, By Product Type
- Global Lipid Panel Test Market, By Application
- Global Lipid Panel Test Market, By Prescription Mode
- Global Lipid Panel Test Market, By End User
- Global Lipid Panel Test Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Lipid Panel Test Market, By Test Type, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Standard Lipid Profile
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  - Total Cholesterol
  - Triglycerides
  - Low-Density Lipoprotein (LDL) Cholesterol
  - High-Density Lipoprotein (HDL) Cholesterol
Advanced Lipid Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  - LDL Particle Number (LDL-P)
  - Apolipoprotein B (ApoB)
  - Lipoprotein(a) (Lp(a))
  - Others (HDL Subclasses, VLDL Cholesterol etc.)

5. Global Lipid Panel Test Market, By Product Type, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  - Automated Analyzers
  - Point-of-Care Testing Devices
  - Spectrophotometers
  - Others
Reagents and Kits
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  - Cholesterol Test Kits
  - HDL and LDL Kits
  - Triglyceride Test Kits
  - Test Strips
  - Other Product Types

6. Global Lipid Panel Test Market, By Application, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hyperlipidemia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Hypertriglyceridemia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Familial Hypercholesterolemia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Hypo Lipoproteinemia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Tangier Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Atherosclerosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Other Lipid Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Global Lipid Panel Test Market, By Prescription Mode, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Prescription-Based Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Over-the-Counter (OTC) Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

8. Global Lipid Panel Test Market, By End User, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Pathology Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Diagnostic Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Home Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

9. Global Lipid Panel Test Market, By Region, 2021 - 2033, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Prescription Mode, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Prescription Mode, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Prescription Mode, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Prescription Mode, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Prescription Mode, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Prescription Mode, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Beckman Coulter Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Hoffmann-La Roche Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Randox Laboratories Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Siemens Healthcare GmbH
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bio-Rad Laboratories Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Nova Biomedical Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
SD Biosensor, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
PTS Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Horiba Medical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Elitech Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Menarini Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
VivaChek Biotech (Hangzhou) Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Mico Bio Med
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies